Morning Market Losers By: Benzinga via Benzinga February 02, 2015 at 09:56 AM EST Ardelyx, Inc. (NASDAQ: ARDX) shares dropped 27.75% to $19.51 after the company announced results from Phase 2b clinical trial ... Read More >> Related Stocks: Ardelyx Inc Fti Consulting Nv5 Global Pitney Bowes Pluristem Therapeutc Sysco Corp